Effectiveness of rotavirus vaccination in Spain

Martinón Torres, Federico; Bouzón Alejandro, Marta; Redondo Collazo, Lorenzo; Sanchez Lastres, J. M.; Pertega Diaz, Sonia; Seoane Pillado, María Teresa; Martinón Sánchez, José María; Alvarez Garcia, F.; Alvarez Garnelo, E.; Amado Puentes, A.; Andres Andres, A. G.; Ares Alvarez, J.; Baza Vilarino, C.; Boullosa Estevez, M.; Busto Cuinas, M.; Caamano Gonzalez, M.; Carballeira Gonzalez, I.; Carballo Silva Mo, A.; Castellon Gallego, A.; Crespo Suarez, P.; Del Rio Pastoriza, I.; Gonzalez Conde Ma, V.; Fernandez Martinez, N.; Fernandez Perez, M. A.; Garcia Sendon, C.; Kamal Kdamel, M.; Lago Mandado, P.; Lia Taborda, A.; Lopez Del Olmo Mo, C.; Lopez Franco, M.; Lopez Sousa, M.; Martinez Abad, P.; Martinon Torres, N.; Miguelez Diaz, R.; Molinos Norniella, C.; Murias Taboada Mo, C.; Ordonez Alvarez, F. A.; Perez Gomez, E.; Perez Lopez, A.; Portugueses De La Red, M.; Rodriguez De La Rua Fernandez, V.; Rodriguez Suarez, J.; Sampedro Campos, Manuel; Suarez Otero, G.; Torre Rodriguez, I.; Vadillo Gonzalez, F.
Thumbnail
Estatísticas
Estatísticas
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/2985
PMID: 21521947
ISSN: 1554-8600
Rexistro completo
Servizos
Servizos
RISMendeleyLinksolver
Visualización ou descarga de ficheiros
Visualización ou descarga de ficheiros
Data de publicación
2011
Título da revista
Human Vaccines
Tipo de contido
Artigo
MeSH
Female | Humans | Male | Spain | Infant | Infant, Newborn | Hospitalization | Rotavirus Vaccines | Gastroenteritis | Rotavirus Infections | Rotavirus | Vaccination
Resumo
With the aim of determining rotavirus vaccine effectiveness (RVVE) in Spain, from Oct-2008/Jun-2009, 467 consecutive children below 2 years old with acute gastroenteritis (AGE) were recruited using a pediatric research network (ReGALIP-www.regalip.org) that includes primary, emergency and hospital care settings. Of 467 enrolled children, 32.3% were rotavirus positive and 35.0% had received at least one dose of any rotavirus vaccine. RRVE to prevent any episode of rotavirus AGE was 91.5% (95% CI: 83.7%-95.6%). RVVE to prevent hospitalization by rotavirus AGE was 95.6% (85.6-98.6%). No differences in RVVE were found regarding the vaccine used. Rotavirus vaccines have showed an outstanding effectiveness in Spain.